| Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe |
| Recruiting | N/A | 40 | Europe | Canagliflozin 300 MG Oral Tablet | Hospital Universitari Vall d'Hebron Research Institute | Postprandial Hypoglycemia | 12/19 | 12/22 | | |
| Recruiting | N/A | 30 | Europe | SGLT2 inhibitor, Dapagliflozin, Empagliflozin, Canagliflozin | University of Turin, Italy | Diabetes Mellitus, Type 2, Arterial Hypertension, Body Weight Changes | 07/20 | 10/20 | | |
NCT05764811: SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity |
|
|
| Completed | N/A | 40 | RoW | Canagliflozin 100mg, standard of care | National Cheng-Kung University Hospital | Fatty Liver Disease | 12/22 | 12/22 | | |
NCT05422092: Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease |
|
|
| Not yet recruiting | N/A | 80 | NA | Canagliflozin, Canagliflozin tablets, Pioglitazone, Pioglitazone Hydrochloride Tablets | First Affiliated Hospital Xi'an Jiaotong University | Type 2 Diabetes Mellitus With Complication | 01/23 | 12/23 | | |
| Completed | N/A | 239990 | Europe | Canagliflozin, DPP4 inhibitor, Liraglutide, Saxagliptin, 2nd generation Sulfonylurea | AstraZeneca | Type 2 Diabetes Mellitus | 08/23 | 08/23 | | |
NCT05347459: Cognitive Protective Effect of Newer Antidiabetic Drugs |
|
|
| Recruiting | N/A | 100 | RoW | Dapagliflozin, Empagliflozin, Canagliflozin, Sitagliptin, Saxagliptin, Linagliptin, Vildagliptin | Alexandria University | Type 2 Diabetes | 12/23 | 12/23 | | |
ChiCTR2300074382: Effect of loxenatide vs. canagliflozin in patients with type 2 diabetes mellitus and sarcopenia: A randomized, open, controlled and single-site clinical trail |
|
|
| Not yet recruiting | N/A | 58 | | Cargliflozin + Metformin ;Losenatide+Metformin | Nanjing Drum Towre Hospital; Nanjing Drum Towre Hospital, China International Exchange Foundation Senmei China Diabetes Research Fund | sarcopenia | | | | |
NCT05135039: Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV. |
|
|
| Recruiting | N/A | 218 | RoW | Canagliflozin, Placebo | xiaolong zhao | PreDiabetes, Hiv | 06/24 | 12/24 | | |
ChiCTR2300073929: Effect of finerenone combined with canagliflozin on urinary protein in patients with chronic kidney disease with type 2 diabetes mellitus: A randomized controlled trial |
|
|
| Not yet recruiting | N/A | 100 | | finerenone in combination with canagliflozin ;finerenone | The Third Hospital of Mianyang, Sichuan Mental Health Center; The Third Hospital of Mianyang, Health Commission of Mianyang City | chronic kidney disease with type 2 diabetes mellitus | | | | |
NCT05903703: Canagliflozin With Gemcitabine in Pancreatic Carcinoma |
|
|
| Not yet recruiting | N/A | 20 | RoW | Canagliflozin and Gemcitabine, Gemcitabine | Zhang Xiaofeng,MD, College of Pharmaceutical Sciences at Zhejiang University, The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University | Pancreatic Cancer | 09/26 | 03/27 | | |
